Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Historical Growth of the Analgesics Market: Insights into Expanding Industry Size
The size of the analgesics market has seen a consistent increase over the past few years. The market, which is estimated to be $110.47 billion in 2024, is projected to further expand and hit $113.1 billion in 2025, indicating a compound annual growth rate (CAGR) of 2.4%.
This historic growth can be associated with factors such as the influence of alternative therapies, results of safety and efficacy studies, prevalence of pain, marketing and promotional strategies, and various economic aspects.
The market for analgesics is anticipated to experience a consistent expansion in the subsequent years, reaching $127.81 billion by 2029 with a compound annual growth rate (CAGR) of 3.1%. Factors such as pain management alternatives, market competition, increased awareness of consumer health, demographic changes and escalating chronic diseases can explain the anticipated growth in the forecast period.
Prominent trends during this period are expected to encompass personalized medicine, non-opioid substitutes, usage of CBD and cannabinoids, focused pain management, and overall accessibility and affordability.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
Which Primary Drivers Are Boosting the Analgesics Market’s Performance?
The increase in the occurrence of chronic diseases is fueling the growth of the analgesics market. Also known as painkillers, analgesic drugs are utilized for the treatment and alleviation of severe or chronic pain resulting from a variety of medical conditions.
For example, in accordance with a report by WHO, a Switzerland-based health organization, in September 2022, noncommunicable diseases (NCDs), also known as chronic diseases, are illnesses that develop over a longer time span due to a mix of genetic, physiological, environmental, and behavioral factors. NCDs are responsible for 41 million deaths annually, representing 74% of all deaths globally.
Further, before turning 70, 17 million people die from an NCD each year. This premature mortality represents 86% of deaths in lower to middle-income countries, with 77% of deaths caused by NCDs also occurring in these regions.
Thus, the escalating prevalence of chronic ailments is propelling the expansion of the analgesics market.
Which Key Segments Are Driving Growth in the Analgesics Market?
The analgesics market covered in this report is segmented –
1) By Type: Non-opioids, Opioids
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores
3) By Application: Internal Analgesics, External Analgesics
Subsegments:
1) By Non-Opioids: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Acetaminophen (Paracetamol), Salicylates
2) By Opioids: Natural Opioids, Semi-Synthetic Opioids, Synthetic Opioids
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the Key Trends Forecasted to Reshape the Analgesics Industry Structure?
Investment as a growth strategy is becoming increasingly popular amongst analgesics market companies. Major analgesic drug producers are financially supporting clinical-stage businesses to maintain their market dominance and develop a competitive edge.
Such investments enable companies to have a broader geographical presence and expertise in the discovery and development of innovative products. For example, in January 2022, the US-based, clinical-stage biopharmaceutical corporation, Concentric Analgesics, Inc., successfully completed a $20 million convertible note funding procedure, with the contribution of both new and current investors.
The funds obtained will kickstart Phase 3 research for Vocacapsaicin, the company’s leading product candidate, which is ready for Phase 3. Further, Concentric Analgesics will use the funds to conduct additional Phase 3 development activities for Vocacapsaicin, their principal candidate for treating post-surgical pain.
The financing’s successful completion marks a significant milestone for Concentric Analgesics, allowing for the progression of Vocacapsaicin into Phase 3 development. It also signifies a vital initial step towards securing the program’s full financial backing through NDA submission.
Which Geographies Are Leading the Expansion of the Analgesics Market?
North America was the largest region in the analgesics market in 2024. Middle East is expected to be the fastest-growing region in the global analgesics market during the forecast period.
The regions covered in the analgesics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Top Companies Dominating the Analgesics Market in 2025?
Major companies operating in the analgesics market include Pfizer Inc., Johnson & Johnson Services Inc., Medley Pharmaceuticals Limited, AbbVie Inc., Bayer HealthCare Pharmaceuticals LLC, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca Plc., Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical company Limited, Eli Lilly and Company, Reckitt Benckiser Group plc, Viatris Inc., Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Limited, Purdue Pharma L.P, Cipla Limited, Allergan Inc., Endo International plc, Amneal Pharmaceuticals LLC, Mallinckrodt Pharmaceuticals Ltd., Chattem Inc., Hisamitsu Pharmaceutical Co.Inc., GW Pharmaceuticals, Verve Health Care Ltd., Alder BioPharmaceuticals Inc., Achelios Therapeutics Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, McNeil Consumer & Specialty Medical Products, Innovative Med Concepts LLC
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=2438
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
